HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

TLE1 is a robust diagnostic biomarker for synovial sarcomas and correlates with t(X;18): analysis of 319 cases.

AbstractINTRODUCTION:
Genomewide expression profiling has identified a number of genes expressed at higher levels in synovial sarcoma than in other sarcomas. Our objectives in this study were (1) to test whether the differentially expressed gene, Transducin-Like Enhancer of split (TLE1) belonging to the groucho/TLE family, is also distinct on the protein level; (2) to evaluate this biomarker in a series of well-characterised synovial sarcomas on standard, full-sized tissue sections and (3) to correlate the expression of TLE1 with t(X;18) and other established biomarkers.
METHODS:
Three-hundred and eighty four spindle cell sarcomas from the German consultation and reference centre of soft tissue tumours initially suspected for synovial sarcoma were revisited. Three-hundred and nineteen of these specimens were analysed immunohistochemically using a monoclonal antibody TLE1 and standard, full-sized tissue sections. The nuclear staining was scored semiquantitatively as -, negative; +, weak; ++, moderate and +++, strong positive. Furthermore, 118 specimens among these were further analysed using FISH and/or PCR to detect t(X;18). We correlated the TLE1 expression with the t(X;18) translocation and other established biomarkers (EMA, PanCK, CK7, CD34 and BCL2).
RESULTS:
TLE1 expression was observed in 96% of the synovial sarcomas (score+, 249/259) and discriminates them from other soft tissue tumours (p<0.001). Multivariate analysis showed that positive TLE1 staining was a statistically independent diagnostic marker. Furthermore molecular analysis showed that t(X;18) was clearly correlated with TLE1 protein expression (p<0.001).
CONCLUSIONS:
Expression of TLE1 is significantly correlated with t(X;18) and may serve as a new robust diagnostic biomarker in synovial sarcomas and potential therapeutic target.
AuthorsThomas Knösel, Sarah Heretsch, Annelore Altendorf-Hofmann, Petra Richter, Kathrin Katenkamp, Detlef Katenkamp, Alexander Berndt, Iver Petersen
JournalEuropean journal of cancer (Oxford, England : 1990) (Eur J Cancer) Vol. 46 Issue 6 Pg. 1170-6 (Apr 2010) ISSN: 1879-0852 [Electronic] England
PMID20189377 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCrown Copyright (c) 2010. Published by Elsevier Ltd. All rights reserved.
Chemical References
  • Biomarkers, Tumor
  • Co-Repressor Proteins
  • Repressor Proteins
  • TLE1 protein, human
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor (genetics, metabolism)
  • Child
  • Chromosomes, Human, 16-18 (genetics)
  • Chromosomes, Human, X (genetics)
  • Co-Repressor Proteins
  • Female
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Male
  • Middle Aged
  • Repressor Proteins (genetics, metabolism)
  • Sarcoma (genetics, metabolism)
  • Sarcoma, Synovial (genetics, metabolism)
  • Soft Tissue Neoplasms (genetics, metabolism)
  • Translocation, Genetic (genetics)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: